Combination HRT raises women's risk of lung cancer

02/25/2010 | Reuters

Hormone replacement therapy containing estrogen and progestin increases the risk of lung cancer in women, according to study data. Women who used the combination HRT for 10 years or more were almost 50% more likely to be diagnosed with lung cancer compared with nonusers, even after taking into consideration age and smoking history.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA